|
|||||
|
Latest Insider Trading | Top Insider Trading Recent Week | Top 10% Owner Trading Recent Week | Filter |
Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Form 4 |
---|---|---|---|---|---|---|---|---|---|
NUVL | Turner Christopher Durant | Chief Medical Officer | Oct 04 | Option Exercise | 6.89 | 7,995 | 55,086 | 22,508 | Oct 06 04:58 PM |
NUVL | Turner Christopher Durant | Chief Medical Officer | Oct 04 | Sale | 54.04 | 7,995 | 432,031 | 14,513 | Oct 06 04:58 PM |
NUVL | Turner Christopher Durant | Chief Medical Officer | Jul 28 | Option Exercise | 6.89 | 2,665 | 18,362 | 17,178 | Jul 28 04:51 PM |
NUVL | Turner Christopher Durant | Chief Medical Officer | Jul 26 | Option Exercise | 6.89 | 2,365 | 16,295 | 16,878 | Jul 28 04:51 PM |
NUVL | Turner Christopher Durant | Chief Medical Officer | Jul 26 | Sale | 46.85 | 2,365 | 110,800 | 14,513 | Jul 28 04:51 PM |
NUVL | Turner Christopher Durant | Chief Medical Officer | Jul 28 | Sale | 48.93 | 2,665 | 130,398 | 14,513 | Jul 28 04:51 PM |
NUVL | Turner Christopher Durant | Chief Medical Officer | Jul 20 | Option Exercise | 6.89 | 100 | 689 | 14,613 | Jul 24 04:54 PM |
NUVL | Turner Christopher Durant | Chief Medical Officer | Jul 24 | Option Exercise | 6.89 | 200 | 1,378 | 14,713 | Jul 24 04:54 PM |
NUVL | Turner Christopher Durant | Chief Medical Officer | Jul 24 | Sale | 46.82 | 200 | 9,364 | 14,513 | Jul 24 04:54 PM |
NUVL | Turner Christopher Durant | Chief Medical Officer | Jul 20 | Sale | 46.80 | 100 | 4,680 | 14,513 | Jul 24 04:54 PM |
NUVL | Turner Christopher Durant | Chief Medical Officer | Jun 05 | Option Exercise | 6.89 | 10,235 | 70,519 | 24,748 | Jun 07 04:50 PM |
NUVL | Turner Christopher Durant | Chief Medical Officer | Jun 05 | Sale | 44.86 | 10,235 | 459,142 | 14,513 | Jun 07 04:50 PM |
NUVL | Turner Christopher Durant | Chief Medical Officer | May 17 | Option Exercise | 6.89 | 14,513 | 99,995 | 14,513 | May 19 04:36 PM |
Join thousands of traders who make more informed decisions with our premium features. Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite